{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:17:23Z","timestamp":1793197043638,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.semarthrit.2014.05.008","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T17:48:46Z","timestamp":1399657726000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"44","author":[{"given":"Nisha","family":"Nigil Haroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeevitha","family":"Sriganthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayef","family":"Al Ghanim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.05.008_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","article-title":"Population based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"Bremander","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s001980170084","article-title":"Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study","volume":"12","author":"Maillefert","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11926-010-0122-1","article-title":"Osteoporosis in ankylosing spondylitis","volume":"12","author":"Magrey","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-010-1338-7","article-title":"The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis","volume":"22","author":"Arends","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","article-title":"High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review","volume":"31","author":"Van der Weijden","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib6","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/ard.2008.100503","article-title":"Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case\u2013control study","volume":"68","author":"Vosse","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3899\/jrheum.100363","article-title":"Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases\u2014a case\u2013control study with 53,108 patients with fracture","volume":"37","author":"Weiss","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib8","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3899\/jrheum.120316","article-title":"Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton","volume":"39","author":"Klingberg","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/39.1.85","article-title":"The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density","volume":"39","author":"Mitra","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.100851","article-title":"Prevalence of vertebral fractures by semi automated morphometry in patients with ankylosing spondylitis","volume":"38","author":"Montala","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.300.6724.563","article-title":"Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis","volume":"300","author":"Ralston","year":"1990","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/11596880-000000000-00000","article-title":"Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization","volume":"30","author":"Budhia","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM200301233480417","article-title":"Inhibition of tumor necrosis factor alpha and ankylosing spondylitis","volume":"348","author":"Asli","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/art.11017","article-title":"Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis","volume":"48","author":"Brandt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2007.076711","article-title":"Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"67","author":"Gengenbacher","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib18","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.2007.084426","article-title":"Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis","volume":"68","author":"Visvanathan","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jbspin.2010.05.010","article-title":"The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis","volume":"78","author":"Kang","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib21","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/ar3823","article-title":"The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study","volume":"14","author":"Arends","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib22","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1186\/ar4055","article-title":"Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?","volume":"14","author":"Saad","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kes364","article-title":"The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis","volume":"52","author":"Kang","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib24","first-page":"855","article-title":"Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment","volume":"35","author":"Briot","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib25","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3899\/jrheum.121417","article-title":"Increase in bone density in ankylosing spondylitis during antiTNF therapy: a 6-year follow-up study","volume":"40","author":"Durnez","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10067-012-2128-8","article-title":"Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study","volume":"32","author":"Dischereit","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","article-title":"Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications","volume":"22","author":"El Maghraoui","year":"2011","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2014.05.008_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-010-1462-4","article-title":"Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis","volume":"22","author":"Confavreux","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2008.04.004","article-title":"Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy","volume":"39","author":"Barnabe","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1759720X12441275","article-title":"Biologicals and bone loss","volume":"4","author":"Krieckaert","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-012-2113-8","article-title":"Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease","volume":"24","author":"Ricciardi","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/BOR.0b013e328356d212","article-title":"Effects of anti-tumor necrosis factor \u03b1 agents on bone","volume":"24","author":"Kawai","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib33","first-page":"115","article-title":"Effects of biologic antirheumatic treatments on bone metabolism in rheumatoid arthritis and ankylosing spondylitis","volume":"60","author":"G\u0142uszko","year":"2009","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2474-13-191","article-title":"Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis","volume":"13","author":"Taylan","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib35","first-page":"1184","article-title":"Bone loss in ankylosing spondylitis: can we put the puzzle together?","volume":"32","author":"Wendling","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.62.4.347","article-title":"Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha","volume":"62","author":"Allali","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.62.10.1020","article-title":"Bone mineral density improvement in spondyloarthropathy after treatment with etanercept","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib38","first-page":"S185","article-title":"Infliximab in spondylarthropathy\u2014influence on bone density","volume":"20","author":"Demis","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib39","unstructured":"Wells G, Shea B, O\u05f3Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. \u3008www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm\u3009; 2011 [accessed June 2013]."},{"key":"10.1016\/j.semarthrit.2014.05.008_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.2004.028670","article-title":"Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment","volume":"64","author":"Briot","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bone.2005.04.038","article-title":"The relative contributions of lean tissue mass and fat mass to bone density in young women","volume":"37","author":"Wang","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib44","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kem069","article-title":"Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50mg once-weekly and 25mg twice-weekly","volume":"46","author":"Braun","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib45","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2011.04667.x","article-title":"Review article: the effects of antitumor necrosis factor-\u03b1 on bone metabolism in inflammatory bowel disease","volume":"33","author":"Veerappan","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2014.05.008_bib47","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The Impact of TNF-inhibitors on radiographic progression in ankylosing spondylitis","volume":"65","author":"Haroon","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721400078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721400078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T15:25:11Z","timestamp":1716737111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721400078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S004901721400078X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}